Jason Haas
Chief Financial Officer; Director · 2 filings · Latest: Jun 5, 2026
LIGAND PHARMACEUTICALS INC
Odyssey Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ODTX | Jason Haas | Chief Financial Officer | May 8, 2026 | Purchase | $20.00 | 1,000 | $20.0K | 62,908 |